Gene Therapy Strategy for Long-Term Myocardial Protection Using Adeno-Associated Virus-Mediated Delivery of Heme Oxygenase Gene
- 5 February 2002
- journal article
- other
- Published by Wolters Kluwer Health in Circulation
- Vol. 105 (5) , 602-607
- https://doi.org/10.1161/hc0502.103363
Abstract
Background— Ischemia and oxidative stress are the leading mechanisms for tissue injury. An ideal strategy for preventive/protective therapy would be to develop an approach that could confer long-te...Keywords
This publication has 26 references indexed in Scilit:
- Induction of Heme Oxygenase-1 Can Act Protectively against Cardiac Ischemia/Reperfusion in VivoBiochemical and Biophysical Research Communications, 2000
- Adeno-associated virus vectors for gene therapy: more pros than cons?Molecular Medicine Today, 2000
- Protective responses in the ischemic myocardiumJournal of Clinical Investigation, 2000
- Regulatable systems: applications in gene therapy and replicating virusesJournal of Clinical Investigation, 2000
- Immune responses to adenovirus and adeno-associated virus in humansGene Therapy, 1999
- The ferritins: molecular properties, iron storage function and cellular regulationPublished by Elsevier ,1999
- Expression of heme oxygenase-1 can determine cardiac xenograft survivalNature Medicine, 1998
- Long-Term Gene Transfer in Porcine Myocardium After Coronary Infusion of an Adeno-Associated Virus VectorThe Annals of Thoracic Surgery, 1996
- Heme oxygenase: A novel target for the modulation of inflammatory responseNature Medicine, 1996
- Bilirubin Is an Antioxidant of Possible Physiological ImportanceScience, 1987